Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Biocompatible poly(L-lactide)/MWCNT nanocomposites: morphological characterization, electrical properties, and stem cell interaction.

Lizundia E., Sarasua JR., D'Angelo F., Orlacchio A., Martino S., Kenny JM.

Laboratory Study on Face & Skin, published in Macromol Biosci (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Macromol Biosci (2012)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
22711658
DOI
10.1002/mabi.201200008

Abstract (original English)

The promising perspectives of PLLA-based nanostructured biomaterials and their relevance in tissue engineering are reported. Nanocomposites based on PLLA and MWCNTs are developed with an MWCNT content ranging from 0 to 3 wt%. The electrical properties show a percolation threshold within a range of 0.21-0.33 wt% MWCNTs, and the conductivity increases by six orders of magnitude. The surface structure shows changes with the carbon nanotube concentration. The functional role of MWCNTs incorporation in terms of interactions with adult stem cells suggests that PLLA/MWCNT nanocomposites are suitable substrates for primary stem cell culture.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdult Stem CellsBiocompatible MaterialsCell CommunicationCell DifferentiationCell SurvivalElectric ConductivityFluorescent Antibody TechniqueHumansMicroscopy, Atomic Force

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research